BioSpectrum Asia|June 2020
What are the major plans in store for Cytiva? Any new segments to be explored?
Cytiva offers the same high-quality services as we did when we were part of GE Healthcare Life Sciences. It shouldn’t be overlooked that we are already a life sciences global leader and we expect our significant growth of recent years to continue. We have been at the forefront of innovation and development of areas such as protein purification, single-use technology and cell and gene therapies. Cytiva will benefit from being a newly-created organization that is already a global life sciences leader. We have market-leading brands such as ÄKTA, Amersham, HyClone and Whatman, among others. We also have more than 100,000 systems in use globally. We will continue innovating from within and working with our customers to develop next-generation solutions. One area where we want to and must do better is sustainability. This is a challenge and opportunity for any organization operating today and one that Cytiva takes very seriously. We don’t want to be just compliant in sustainability terms, we want to lead the industry. We will be focusing on areas such as GHG emission, use of plastics, packaging, water management and societal impact among other areas.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories and 5,000+ magazines
READ THE ENTIRE ISSUE